Cargando…

Pharmacological Interactions in the Elderly

Pharmacological therapy in the elderly is particularly complicated and challenging. Due to coexistence of three main predisposing factors (advanced age, multiple morbidity and polypharmacotherapy), this group of patients is prone to occurrence of drug interactions and adverse effects of incorrect dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Błeszyńska, Emilia, Wierucki, Łukasz, Zdrojewski, Tomasz, Renke, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404696/
https://www.ncbi.nlm.nih.gov/pubmed/32605319
http://dx.doi.org/10.3390/medicina56070320
_version_ 1783567168460292096
author Błeszyńska, Emilia
Wierucki, Łukasz
Zdrojewski, Tomasz
Renke, Marcin
author_facet Błeszyńska, Emilia
Wierucki, Łukasz
Zdrojewski, Tomasz
Renke, Marcin
author_sort Błeszyńska, Emilia
collection PubMed
description Pharmacological therapy in the elderly is particularly complicated and challenging. Due to coexistence of three main predisposing factors (advanced age, multiple morbidity and polypharmacotherapy), this group of patients is prone to occurrence of drug interactions and adverse effects of incorrect drug combinations. Since many years patient safety during the treatment process has been one of key elements for proper functioning of healthcare systems around the world, thus different preventive measures have been undertaken in order to counteract factors adversely affecting the therapeutic effect. One of the avoidable medical errors is pharmacological interactions. According to estimates, one in six elderly patients may be at risk of a significant drug interaction. Hence the knowledge about mechanisms and causes of drug interactions in the elderly, as well as consequences of their occurrence are crucial for planning the process of pharmacotherapy. For the purpose of pharmacovigilance, a review of available methods and tools gives an insight into possible ways of preventing drug interactions. Additionally, recognizing the actual scale of this phenomenon in geriatric population around the world emphasizes the importance of a joint effort among medical community to improve quality of pharmacotherapy.
format Online
Article
Text
id pubmed-7404696
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74046962020-08-11 Pharmacological Interactions in the Elderly Błeszyńska, Emilia Wierucki, Łukasz Zdrojewski, Tomasz Renke, Marcin Medicina (Kaunas) Review Pharmacological therapy in the elderly is particularly complicated and challenging. Due to coexistence of three main predisposing factors (advanced age, multiple morbidity and polypharmacotherapy), this group of patients is prone to occurrence of drug interactions and adverse effects of incorrect drug combinations. Since many years patient safety during the treatment process has been one of key elements for proper functioning of healthcare systems around the world, thus different preventive measures have been undertaken in order to counteract factors adversely affecting the therapeutic effect. One of the avoidable medical errors is pharmacological interactions. According to estimates, one in six elderly patients may be at risk of a significant drug interaction. Hence the knowledge about mechanisms and causes of drug interactions in the elderly, as well as consequences of their occurrence are crucial for planning the process of pharmacotherapy. For the purpose of pharmacovigilance, a review of available methods and tools gives an insight into possible ways of preventing drug interactions. Additionally, recognizing the actual scale of this phenomenon in geriatric population around the world emphasizes the importance of a joint effort among medical community to improve quality of pharmacotherapy. MDPI 2020-06-28 /pmc/articles/PMC7404696/ /pubmed/32605319 http://dx.doi.org/10.3390/medicina56070320 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Błeszyńska, Emilia
Wierucki, Łukasz
Zdrojewski, Tomasz
Renke, Marcin
Pharmacological Interactions in the Elderly
title Pharmacological Interactions in the Elderly
title_full Pharmacological Interactions in the Elderly
title_fullStr Pharmacological Interactions in the Elderly
title_full_unstemmed Pharmacological Interactions in the Elderly
title_short Pharmacological Interactions in the Elderly
title_sort pharmacological interactions in the elderly
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404696/
https://www.ncbi.nlm.nih.gov/pubmed/32605319
http://dx.doi.org/10.3390/medicina56070320
work_keys_str_mv AT błeszynskaemilia pharmacologicalinteractionsintheelderly
AT wieruckiłukasz pharmacologicalinteractionsintheelderly
AT zdrojewskitomasz pharmacologicalinteractionsintheelderly
AT renkemarcin pharmacologicalinteractionsintheelderly